Welcome to Igenomix
Come into the new age of science
Diagnóstico Genómico de Precisión
Asesoramiento genético a médicos y pacientes.
Hemos ampliado nuestro portfolio con el nuevo servicio integral de diagnóstico genético, que cubre todas las etapas de la vida, gracias a las diferentes tecnologías empleadas (single gene, CMA, etc.) y más de 250 paneles de diferentes especialidades.
Prenatal genetic diagnosis integral service
- El Diagnóstico Genético Prenatal es un servicio que identifica alteraciones genéticas en el feto que pueden suponer un trastorno durante el embarazo o el período neonatal que es clínicamente procesable.
- Un 6-8% de embarazos son de alto riesgo
- Un 3-5% de embarazosos encuentran ultrasound findings
- El 3% de bebés recién nacidos presentan defectos congenitos
Newborn Screening
Comprehensive genetic test
Newborn Screening Test (NBS) is a comprehensive genetic test that includes 104 genes analyzed using Next Generation Sequencing (NGS) technologies allowing a direct approach of genetic disorders to reach an accurate diagnosis. It is a screening test of genetic actionable diseases indicated for all newborns and performed during the first days of life.
- Diseases with high prevalence rates.
- Detect diseases where you can take action to improve prognosis.
- Genes selected according to evidence-based medicine.
- Availability and access to treatment.
Clinic Portal
Connecting clinics, specialists, and patients through our digital ecosystem
In Igenomix we want to contribute by making doctor’s daily lives easier. With this idea in mind, we have developed a new Clinic Portal where specialists can manage everything which is necessary to request genetic tests, obtain documentation, request kits and even receive and download their patient’s results. Ask your local delegate for additional information!
Endometrial Health
The endometrium matters
- The ERA test offers a personalized transfer recommendation in the first biopsy in 90% of the samples analyzed
- The ERA test analyzes the 248 genes needed to accurately determine the personalized implantation window for each patient
- 71% of patients that had a personalized embryo transfer, had a baby after one year
- The ERA intelligent algorithm based on Artificial Intelligence can detect 12 hour displacements in the window of implantation
- 30% of infertile women have pathogenic bacteria in their endometrium: EMMA & ALICE test for a 360º view of endometrial health
EMBRACE
Embryo Analysis of Culture Environment
- A non-invasive test for prioritizing embryo transfer that avoids invasive embryo biopsy, potentially increasing accessibility for a wider patient population.
- EMBRACE scores embryos according to their probability of being healthy and viable based on chromosomal information.
- The recent identification of embryo cell-free DNA in spent blastocyst media opened a new era of possibilities for non-invasive embryo aneuploidy testing in assisted reproductive technologies.
Yosu Franco, PhD
Laboratory and Scientific Director of Hospital Ruber Internacional, Madrid, Spain
Poster number: P560
Title: Comparative analysis of non-invasive preimplantation genetic testing of aneuploidies (niPGT-A), PGT-A and IVF cycles without aneuploidy testing: preliminary results.
Screening Diagnostics
CGT our advanced Carrier Genetic test, the most complete Genetic screening test based on Exome sequencing that cover over 2,000 genes that cause more than 2,200 diseases, providing in 20 working days the most accurate test results to future parents giving them the opportunity to make informed decisions and review the range of options available to guide pregnancy and family planning.
Why choose our CS Exome Based?
CLINICAL ADVANTAGE
- Allows for testing of All known recessive conditions.
- Increases the overall detection rate minimizing the global residual risk.
MATCHING
- Matching possible with ALL genetic lab tests in the market.
- Simplifies competitor CS panel mirroring as no resequencing is required to provide matching information.
UPGRADES
- Any upgrade possible at a later date if required
REANALYSIS
- Exome Sequencing offers added value for future analysis of a given patient.
- Provides analytical possibilities in an adverse event of a newborn with a genetic condition.
Do you have any questions?
-
-
General OBGYN Sonographer Nurse Pediatrician Neurology Cardiology Clinical Genetics Hematolgy and Hemotherapy Immunology Allergology Clinical Analysis Laboratory Gastroenterology Dermatology and Venereology Endocrinology and Nutrition Clinial Pharmacology Internal Medicine Nephrology Pneumology Clinial Neurophysiology Ophthalmology Medical Oncology Otorhinolaryngology Psychiatry Rheumatology Urology IVF Doctor Embryologist Head embryologist IVF Geneticist Medical Director Other
-
ALICE CGT EMBRACE EMMA EndomeTRIO ERA NACE NACE 24 PGT-A PGT-M POC SAT PCR COVID-19 ELISA GPDx Exome-genome sequencing GPDx Single Gene Sequencing GPDx Precision panels GPDx CMA Genetic Counseling
-
-